Manufacturing, Cell Therapies

Gilead, Kite, and oNKo-innate Enter into Three-Year Cancer Immunotherapy Research Collaboration

April 22, 2020

The companies will collaborate on the discovery and development of next-generation drug and engineered cell therapies focused on natural killer cells.

Thermo Fisher Scientific Invests $800 Million into New Capabilities and Capacity

March 24, 2020

Thermo Fisher is focused on investing to expand three specific areas of demand: biologics, cell and gene therapy, and drug product development and commercial capabilities.

Inside FDA’s New Gene and Cell Therapy Guidances

March 15, 2020

In January 2020, the agency finalized six clinical development and manufacturing guidance documents and drafted new guidance on what would qualify new gene therapies as orphan drugs.

Optimizing Process Development for Emerging Therapies

March 02, 2020

Tackling process development early on can better optimize manufacturing processes for emerging therapies.

Investments Inject Growth in Cell and Gene Therapies

March 02, 2020

The growing interest in developing cell and gene therapies has prompted industry investment to grow manufacturing capacity.

Industry pushes forward with cell and gene therapies

March 02, 2020

The last year has seen intense investment activity into raising cell and gene therapy manufacturing capacity.

FDA and EMA Accept Biologics Application for Novartis Multiple Sclerosis Cell Therapy

February 27, 2020

If approved, the therapy may become the first-choice treatment for relapsing multiple sclerosis patients and will be the first B-cell therapy that can be self-administered using an autoinjector pen.

GSK and Immatics in $550-Million+ Pact to Develop Adoptive Cell Therapies

February 20, 2020

The companies aim to develop novel cell therapies for treating multiple cancers.

Novartis, Kite, and Cardinal Health Invest in Cell and Gene Therapy Infrastructure

February 10, 2020

New funding brings competitors, and a leading healthcare products distributor, into the standardization effort.

Hitachi Chemical Opens New Cell and Gene Therapy Manufacturing Facility

February 06, 2020

The new facility includes six classified environment rooms with space to expand.